SEARCH

SEARCH BY CITATION

References

  • 1
    Gao Z, Fackler MJ, Leung W, et al. Human CD34+ cell preparations contain over 100-fold greater NOD/SCID mouse engrafting capacity than do CD34 cell preparations. Exp Hematol 2001; 29: 910921.
  • 2
    Civin CI, Trischmann T, Kadan NS, et al. Highly purified CD34-positive cells reconstitute hematopoiesis. J Clin Oncol 1996; 14: 22242233.
  • 3
    Yin AH, Miraglia S, Zanjani ED, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997; 90: 50025012.
  • 4
    Miraglia S, Godfrey W, Yin AH, et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997; 90: 50135021.
  • 5
    Bühring HJ, Marxer A, Lammers R, et al. CD133 cluster report. In: MasonD, AndréP, BensussanA et al. (eds). Leucocyte Typing VII. White Cell Differentiation Antigens. Oxford: Oxford University Press, 2002:622623.
  • 6
    Gordon PR, Leimig T, Babarin-Dorner A, et al. Large-scale isolation of CD133+ progenitor cells from G-CSF mobilized peripheral blood stem cells. Bone Marrow Transplant 2003; 31: 1722.
  • 7
    Conze T, Lammers R, Kuçi S, et al. CDCP1 is a novel marker for hematopoietic stem cells. Ann New York Acad Sci 2003; 996: 222226.
  • 8
    Scherl-Mostageer M, Sommergruber W, Abseher R, et al. Identification of a novel gene, CDCP1, overexpressed in human colorectal cancer. Oncogene 2001; 20: 44024408.
  • 9
    Duke-Cohan JS, Gu J, McLaughlin DF, et al. Attractin (DPPT-L), a member of the CUB family of cell adhesion and guidance proteins, is secreted by activated human T lymphocytes and modulates immune cell interactions. Proc Natl Acad Sci USA 1998; 95: 1133611341.
  • 10
    Bork P, Beckmann G. The CUB domain. A widespread module in developmentally regulated proteins. J Mol Biol 1993; 231: 539545.
  • 11
    Gerstein M, Jansen R. The current excitement in bioinformatics-analysis of whole-genome expression data: how does it relate to protein structure and function? Curr Opin Struct Biol 2000; 10: 574584.
  • 12
    Li SW, Sieron AL, Fertala A, et al. The C-proteinase that processes procollagens to fibrillar collagens is identical to the protein previously identified as bone morphogenic protein-1. Proc Natl Acad Sci USA 1996; 93: 51275130.
  • 13
    Stohr H, Berger C, Frohlich S, et al. A novel gene encoding a putative transmembrane protein with two extracellular CUB domains and a low-density lipoprotein class A module: isolation of alternatively spliced isoforms in retina and brain. Gene 2002; 286: 223231.
  • 14
    Chen C, Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 1987; 7: 27452752.
  • 15
    Heider KH, Hofmann M, Horst E, et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 1993; 120: 227233.
  • 16
    Greaves MF, Titley I, Colman SM, et al. Report on the CD34 cluster workshop. In: SchlossmanSF, BoumsellL, GilkesW et al. (eds). Leucocyte Typing V. Oxford: Oxford University Press, 1995:840846.
  • 17
    Bhatia M. AC133 expression in human stem cells. Leukemia 2001; 15: 16851688.
  • 18
    Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 4149.
  • 19
    Jiang Y, Vaessen B, Lenvik T, et al. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol 2002; 30: 896904.
  • 20
    Hooper JD, Zijlstra A, Aimes RT, et al. Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen. Oncogene 2003; 22: 17831794.
  • 21
    Wimberger P, Xiang W, Mayr D, et al. Efficient tumor cell lysis by autologous, tumor-resident T lymphocytes in primary ovarian cancer samples by an EP-CAM-/CD3-bispecific antibody. Int J Cancer 2003; 105: 241248.
  • 22
    Schweizer C, Strauss G, Lindner M, et al. Efficient carcinoma cell killing by activated polymorphonuclear neutrophils targeted with an Ep-CAMxCD64 (HEA125×197) bispecific antibody. Cancer Immunol Immunother 2002; 51: 621629.
  • 23
    Thor A, Viglione MJ, Ohuchi N, et al. Comparison of monoclonal antibodies for the detection of occult breast carcinoma metastases in bone marrow. Breast Cancer Res Treat 1988; 11: 133145.
  • 24
    Feinberg H, Uitdehaag JC, Davies JM, et al. Crystal structure of the CUB1-EGF-CUB2 region of mannose-binding protein associated serine protease-2. EMBO J 2003; 22: 23482359.
  • 25
    Hartigan N, Garrigue-Antar L, Kadler KE. Bone morphogenetic protein-1 (BMP-1). Identification of the minimal domain structure procollagen C-proteinase activity. J Biol Chem 2003; 278: 1804518049.
  • 26
    Seiffert M, Cant C, Chen Z, et al. Human signal-regulatory protein is expressed on normal but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counter-receptor CD47. Blood 1999; 94: 36333643.